Concepts (178)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Vaccinia virus | 11 | 2004 | 97 | 1.400 |
Why?
|
| Transcription Factors | 9 | 2006 | 753 | 0.870 |
Why?
|
| Transcription, Genetic | 11 | 2004 | 562 | 0.730 |
Why?
|
| Viral Proteins | 6 | 2004 | 150 | 0.620 |
Why?
|
| Rhabdoid Tumor | 3 | 2003 | 9 | 0.580 |
Why?
|
| Gene Expression Regulation, Viral | 3 | 2004 | 38 | 0.460 |
Why?
|
| HeLa Cells | 9 | 2006 | 237 | 0.320 |
Why?
|
| Saccharomyces cerevisiae | 8 | 1988 | 173 | 0.310 |
Why?
|
| Trans-Activators | 3 | 2004 | 237 | 0.260 |
Why?
|
| Chromatin | 1 | 2006 | 76 | 0.260 |
Why?
|
| Heterogeneous-Nuclear Ribonucleoprotein Group A-B | 2 | 2004 | 3 | 0.260 |
Why?
|
| DNA-Binding Proteins | 3 | 2006 | 700 | 0.260 |
Why?
|
| Proto-Oncogene Proteins c-akt | 1 | 2006 | 331 | 0.230 |
Why?
|
| Promoter Regions, Genetic | 6 | 1998 | 615 | 0.230 |
Why?
|
| Mutation | 8 | 1996 | 1213 | 0.220 |
Why?
|
| Cellular Senescence | 1 | 2003 | 112 | 0.200 |
Why?
|
| Base Sequence | 10 | 2001 | 1015 | 0.200 |
Why?
|
| Ribonucleoproteins | 1 | 2001 | 19 | 0.200 |
Why?
|
| Metallothionein | 4 | 1988 | 20 | 0.190 |
Why?
|
| DNA, Viral | 3 | 1996 | 114 | 0.180 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2003 | 756 | 0.160 |
Why?
|
| Kidney Neoplasms | 1 | 1998 | 206 | 0.150 |
Why?
|
| Protein Binding | 3 | 2006 | 1027 | 0.140 |
Why?
|
| Neoplasm Proteins | 1 | 1998 | 307 | 0.130 |
Why?
|
| Genes, Fungal | 5 | 1988 | 24 | 0.130 |
Why?
|
| Genes, Viral | 3 | 1991 | 44 | 0.130 |
Why?
|
| RNA, Messenger | 4 | 2004 | 1664 | 0.130 |
Why?
|
| RNA, Viral | 2 | 2004 | 93 | 0.130 |
Why?
|
| SMARCB1 Protein | 2 | 2006 | 4 | 0.120 |
Why?
|
| Chromosomal Proteins, Non-Histone | 2 | 2006 | 27 | 0.120 |
Why?
|
| Proteins | 1 | 1998 | 474 | 0.120 |
Why?
|
| Adenosine Triphosphate | 3 | 2006 | 314 | 0.120 |
Why?
|
| Genetic Vectors | 3 | 2004 | 312 | 0.110 |
Why?
|
| Viral Structural Proteins | 1 | 1991 | 10 | 0.100 |
Why?
|
| Hodgkin Disease | 1 | 1991 | 27 | 0.100 |
Why?
|
| Herpesvirus 4, Human | 1 | 1991 | 30 | 0.100 |
Why?
|
| Molecular Sequence Data | 5 | 1998 | 1447 | 0.090 |
Why?
|
| Pathology | 1 | 1991 | 17 | 0.090 |
Why?
|
| Copper | 4 | 1988 | 149 | 0.090 |
Why?
|
| Molecular Biology | 1 | 1991 | 31 | 0.090 |
Why?
|
| Cell-Free System | 3 | 1998 | 43 | 0.090 |
Why?
|
| Genes | 2 | 1988 | 86 | 0.080 |
Why?
|
| DNA-Directed RNA Polymerases | 3 | 1995 | 16 | 0.080 |
Why?
|
| Tumor Cells, Cultured | 2 | 2001 | 852 | 0.080 |
Why?
|
| Humans | 14 | 2006 | 68618 | 0.080 |
Why?
|
| Poly A | 1 | 1987 | 14 | 0.080 |
Why?
|
| In Vitro Techniques | 2 | 2004 | 765 | 0.070 |
Why?
|
| Genes, p53 | 2 | 1998 | 41 | 0.070 |
Why?
|
| Tumor Suppressor Protein p53 | 2 | 2001 | 231 | 0.070 |
Why?
|
| Pediatrics | 1 | 1991 | 341 | 0.070 |
Why?
|
| Coliphages | 1 | 1986 | 6 | 0.070 |
Why?
|
| Oligodeoxyribonucleotides | 1 | 1986 | 35 | 0.070 |
Why?
|
| Escherichia coli | 3 | 1995 | 368 | 0.070 |
Why?
|
| Blotting, Western | 3 | 2001 | 954 | 0.070 |
Why?
|
| Erythroid-Specific DNA-Binding Factors | 1 | 2006 | 9 | 0.070 |
Why?
|
| Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 1 | 2006 | 24 | 0.070 |
Why?
|
| Cytochrome c Group | 1 | 1985 | 22 | 0.070 |
Why?
|
| Cytochromes c | 1 | 1985 | 75 | 0.070 |
Why?
|
| Cytoplasm | 1 | 2006 | 155 | 0.060 |
Why?
|
| Plasmids | 5 | 1987 | 258 | 0.060 |
Why?
|
| Deoxyribonucleases, Type II Site-Specific | 1 | 1984 | 8 | 0.060 |
Why?
|
| Actins | 1 | 2006 | 249 | 0.060 |
Why?
|
| Amino Acid Sequence | 3 | 2001 | 1083 | 0.060 |
Why?
|
| Polymerase Chain Reaction | 3 | 1996 | 492 | 0.060 |
Why?
|
| Gene Expression Regulation | 4 | 1988 | 1293 | 0.060 |
Why?
|
| Gene Amplification | 2 | 1996 | 71 | 0.060 |
Why?
|
| Bacteriophage phi X 174 | 1 | 1983 | 2 | 0.060 |
Why?
|
| Tumor Stem Cell Assay | 1 | 2003 | 30 | 0.050 |
Why?
|
| Phosphorylation | 1 | 2006 | 1200 | 0.050 |
Why?
|
| Kidney Tubules, Proximal | 1 | 2003 | 81 | 0.050 |
Why?
|
| Genes, Tumor Suppressor | 1 | 2003 | 61 | 0.050 |
Why?
|
| RNA-Binding Proteins | 1 | 2004 | 215 | 0.050 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2003 | 282 | 0.050 |
Why?
|
| Adenoviridae | 1 | 2003 | 295 | 0.050 |
Why?
|
| DNA Repair | 1 | 1983 | 127 | 0.050 |
Why?
|
| Gene Expression | 1 | 2004 | 770 | 0.050 |
Why?
|
| Chromatography, DEAE-Cellulose | 1 | 2001 | 14 | 0.050 |
Why?
|
| Cell Cycle | 1 | 2003 | 312 | 0.050 |
Why?
|
| Heterogeneous-Nuclear Ribonucleoproteins | 1 | 2001 | 32 | 0.050 |
Why?
|
| DNA Primers | 1 | 2001 | 302 | 0.050 |
Why?
|
| DNA Damage | 1 | 2001 | 190 | 0.050 |
Why?
|
| Doxorubicin | 1 | 2001 | 231 | 0.050 |
Why?
|
| Cloning, Molecular | 3 | 1995 | 357 | 0.040 |
Why?
|
| Animals | 5 | 2004 | 20881 | 0.040 |
Why?
|
| Blotting, Northern | 2 | 1998 | 189 | 0.040 |
Why?
|
| Drug Resistance, Neoplasm | 1 | 2001 | 332 | 0.040 |
Why?
|
| Infant, Newborn | 2 | 1998 | 2455 | 0.040 |
Why?
|
| Karyotyping | 1 | 1998 | 74 | 0.040 |
Why?
|
| Loss of Heterozygosity | 1 | 1998 | 25 | 0.040 |
Why?
|
| Cations, Divalent | 1 | 1998 | 27 | 0.040 |
Why?
|
| Chromosomes, Human, Pair 22 | 1 | 1998 | 18 | 0.040 |
Why?
|
| Fluorescent Antibody Technique, Indirect | 1 | 1998 | 95 | 0.040 |
Why?
|
| Chromosome Disorders | 1 | 1998 | 31 | 0.040 |
Why?
|
| Chromatography, Affinity | 1 | 1998 | 73 | 0.040 |
Why?
|
| Infant | 2 | 1998 | 2891 | 0.040 |
Why?
|
| Neoplasm Transplantation | 1 | 1998 | 160 | 0.040 |
Why?
|
| Chromosome Aberrations | 1 | 1998 | 86 | 0.040 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 1998 | 144 | 0.040 |
Why?
|
| Proto-Oncogene Proteins c-myc | 1 | 1998 | 90 | 0.040 |
Why?
|
| Mice, Nude | 1 | 1998 | 294 | 0.040 |
Why?
|
| Mice, Inbred BALB C | 1 | 1998 | 532 | 0.040 |
Why?
|
| Cell Nucleus | 1 | 1998 | 305 | 0.040 |
Why?
|
| Biomarkers | 1 | 2003 | 1593 | 0.040 |
Why?
|
| Proto-Oncogenes | 1 | 1996 | 37 | 0.030 |
Why?
|
| Histiocytoma, Benign Fibrous | 1 | 1996 | 10 | 0.030 |
Why?
|
| Genes, Immediate-Early | 1 | 1996 | 13 | 0.030 |
Why?
|
| Hydroxyurea | 1 | 1996 | 57 | 0.030 |
Why?
|
| DNA Restriction Enzymes | 2 | 1985 | 49 | 0.030 |
Why?
|
| Pneumocystis Infections | 1 | 1995 | 2 | 0.030 |
Why?
|
| Pneumocystis | 1 | 1995 | 3 | 0.030 |
Why?
|
| Rabbits | 1 | 1996 | 509 | 0.030 |
Why?
|
| Recombinant Fusion Proteins | 1 | 1996 | 376 | 0.030 |
Why?
|
| Nuclear Proteins | 1 | 1996 | 271 | 0.030 |
Why?
|
| Chromatography, Ion Exchange | 1 | 1993 | 73 | 0.030 |
Why?
|
| Cellulose | 1 | 1993 | 22 | 0.030 |
Why?
|
| Breast Neoplasms | 1 | 2003 | 1536 | 0.030 |
Why?
|
| Immunohistochemistry | 2 | 1996 | 1174 | 0.030 |
Why?
|
| Cell Line | 1 | 1996 | 1752 | 0.020 |
Why?
|
| Hyperplasia | 1 | 1991 | 89 | 0.020 |
Why?
|
| Molecular Probe Techniques | 1 | 1991 | 7 | 0.020 |
Why?
|
| Gene Rearrangement | 1 | 1991 | 19 | 0.020 |
Why?
|
| Galactokinase | 2 | 1988 | 3 | 0.020 |
Why?
|
| Transcriptional Activation | 1 | 1991 | 226 | 0.020 |
Why?
|
| Communicable Diseases | 1 | 1991 | 50 | 0.020 |
Why?
|
| Lymph Nodes | 1 | 1991 | 258 | 0.020 |
Why?
|
| Biopsy | 1 | 1991 | 540 | 0.020 |
Why?
|
| Homeostasis | 2 | 1988 | 291 | 0.020 |
Why?
|
| RNA | 1 | 1989 | 171 | 0.020 |
Why?
|
| Single-Strand Specific DNA and RNA Endonucleases | 1 | 1987 | 4 | 0.020 |
Why?
|
| Endonucleases | 1 | 1987 | 10 | 0.020 |
Why?
|
| Carrier Proteins | 2 | 1988 | 597 | 0.020 |
Why?
|
| RNA Processing, Post-Transcriptional | 1 | 1987 | 43 | 0.020 |
Why?
|
| Drug Resistance, Microbial | 1 | 1987 | 70 | 0.020 |
Why?
|
| Templates, Genetic | 1 | 1986 | 9 | 0.020 |
Why?
|
| Genes, Bacterial | 1 | 1986 | 40 | 0.020 |
Why?
|
| Mice | 1 | 1998 | 8474 | 0.020 |
Why?
|
| Sulfites | 1 | 1985 | 7 | 0.020 |
Why?
|
| Adolescent | 1 | 1998 | 8912 | 0.020 |
Why?
|
| Mutagens | 1 | 1985 | 18 | 0.020 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 1 | 1985 | 37 | 0.020 |
Why?
|
| Time Factors | 1 | 1993 | 4655 | 0.020 |
Why?
|
| Deoxyribonuclease BamHI | 1 | 1984 | 2 | 0.020 |
Why?
|
| Chromosome Deletion | 1 | 1984 | 41 | 0.020 |
Why?
|
| Child, Preschool | 1 | 1991 | 3187 | 0.010 |
Why?
|
| Phenotype | 1 | 1986 | 947 | 0.010 |
Why?
|
| Osmium Tetroxide | 1 | 1983 | 2 | 0.010 |
Why?
|
| DNA Ligases | 1 | 1983 | 6 | 0.010 |
Why?
|
| Thymidine | 1 | 1983 | 32 | 0.010 |
Why?
|
| DNA, Single-Stranded | 1 | 1983 | 41 | 0.010 |
Why?
|
| DNA, Fungal | 2 | 1995 | 20 | 0.010 |
Why?
|
| Child | 1 | 1991 | 6405 | 0.010 |
Why?
|
| Neoplasms | 1 | 1991 | 1667 | 0.010 |
Why?
|
| Male | 1 | 1998 | 37321 | 0.010 |
Why?
|
| Female | 1 | 1998 | 38074 | 0.010 |
Why?
|
| Proto-Oncogene Proteins c-mdm2 | 1 | 1996 | 24 | 0.010 |
Why?
|
| Soft Tissue Neoplasms | 1 | 1996 | 28 | 0.010 |
Why?
|
| Pentamidine | 1 | 1995 | 7 | 0.010 |
Why?
|
| Sequence Analysis, DNA | 1 | 1996 | 208 | 0.010 |
Why?
|
| Trimethoprim, Sulfamethoxazole Drug Combination | 1 | 1995 | 22 | 0.010 |
Why?
|
| Gene Deletion | 1 | 1996 | 235 | 0.010 |
Why?
|
| Bronchoalveolar Lavage Fluid | 1 | 1995 | 117 | 0.010 |
Why?
|
| Proportional Hazards Models | 1 | 1996 | 792 | 0.010 |
Why?
|
| Proto-Oncogene Proteins | 1 | 1996 | 411 | 0.010 |
Why?
|
| Rats, Sprague-Dawley | 1 | 1995 | 2083 | 0.010 |
Why?
|
| Sulfur | 1 | 1988 | 16 | 0.000 |
Why?
|
| Luminescent Measurements | 1 | 1988 | 58 | 0.000 |
Why?
|
| Sulfhydryl Compounds | 1 | 1988 | 73 | 0.000 |
Why?
|
| Amino Acids | 1 | 1988 | 131 | 0.000 |
Why?
|
| Haplorhini | 1 | 1987 | 44 | 0.000 |
Why?
|
| DNA, Recombinant | 1 | 1987 | 25 | 0.000 |
Why?
|
| Genes, Regulator | 1 | 1987 | 17 | 0.000 |
Why?
|
| Sequence Homology, Nucleic Acid | 1 | 1987 | 95 | 0.000 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 1 | 1987 | 43 | 0.000 |
Why?
|
| Rats | 1 | 1995 | 5300 | 0.000 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 1988 | 618 | 0.000 |
Why?
|
| Kinetics | 1 | 1988 | 1047 | 0.000 |
Why?
|
| Centromere | 1 | 1983 | 15 | 0.000 |
Why?
|
| Oxygen | 1 | 1983 | 386 | 0.000 |
Why?
|